Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 2, 2012, Pages

  Stenmark, Matthew H ^a   Cai, Xu Wei ^a,d   Shedden, Kerby ^b   Hayman, James A ^a   Yuan, Shuanghu ^a,e   Ritter, Timothy ^c   Ten Haken, Randall K ^a   Lawrence, Theodore S ^a   Kong, Feng Ming ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^e SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CYTOKINES; DOSIMETRIC PARAMETER; FRACTIONATED RADIATION; INDEPENDENT PREDICTORS; INFLAMMATORY CYTOKINES; LUNG CANCER; MEAN LUNG DOSE; NON SMALL CELL LUNG CANCER; PLASMA DYNAMICS; PRE-TREATMENT; PREDICTIVE ABILITIES; PROINFLAMMATORY; PULMONARY FIBROSIS; RADIATION PNEUMONITIS; RADIATION-INDUCED; RECEIVER OPERATOR CHARACTERISTIC CURVES; TRANSFORMING GROWTH FACTORS; TUMOR NECROSIS FACTOR ALPHA;

BIOLOGICAL ORGANS; DOSIMETERS; DOSIMETRY; DYNAMICS; FORECASTING; PLASMA DIAGNOSTICS; TOXICITY;

RADIOTHERAPY;

CARBOPLATIN; CISPLATIN; ERLOTINIB; ETOPOSIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PACLITAXEL; PEMETREXED; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; DISEASE COURSE; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREMEDICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RADIATION INDUCED LUNG TOXICITY; RADIATION INJURY; RADIATION PNEUMONIA; RISK ASSESSMENT;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CYTOKINES; DOSE FRACTIONATION; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865614901     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.03.067     Document Type: Article

References (16)

1. M.V. Graham, J.A. Purdy, and B. Emami Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 1999 323 329
2. F.M. Kong, J.A. Hayman, and K.A. Griffith Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis Int J Radiat Oncol Biol Phys 65 2006 1075 1086
3. M.S. Anscher, F.M. Kong, and K. Andrews Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis Int J Radiat Oncol Biol Phys 41 1998 1029 1035
4. M.S. Anscher, L.B. Marks, and T.D. Shafman Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation J Clin Oncol 19 2001 3758 3765
5. K. De Jaeger, Y. Seppenwoolde, and H.H. Kampinga Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 58 2004 1378 1387
6. J.P. Hart, G. Broadwater, and Z. Rabbani Cytokine profiling for prediction of symptomatic radiation-induced lung injury Int J Radiat Oncol Biol Phys 63 2005 1448 1454
7. L. Zhao, L. Wang, and W. Ji Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan Int J Radiat Oncol Biol Phys 74 2009 1385 1390
8. D. Arpin, D. Perol, and J.Y. Blay Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis J Clin Oncol 23 2005 8748 8756
9. X.L. Fu, H. Huang, and G. Bentel Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta Int J Radiat Oncol Biol Phys 50 2001 899 908
10. F.M. Kong, R. Ten Haken, and A. Eisbruch Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis Semin Oncol 32 2005 S42 S54
11. K. Fleckenstein, B. Gauter-Fleckenstein, and I.L. Jackson Using biological markers to predict risk of radiation injury Semin Radiat Oncol 17 2007 89 98
12. F.M. Kong, R.K. Ten Haken, and M.J. Schipper High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study Int J Radiat Oncol Biol Phys 63 2005 324 333
13. N. Mukaida Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases Am J Physiol Lung Cell Mol Physiol 284 2003 L566 L577
14. W.S. Simonet, T.M. Hughes, and H.Q. Nguyen Long-term impaired neutrophil migration in mice overexpressing human interleukin-8 J Clin Invest 94 1994 1310 1319
15. C.E. Rube, J. Palm, and M. Erren Cytokine plasma levels: reliable predictors for radiation pneumonitis? PLoS One 3 2008 e2898
16. Y. Chen, P. Rubin, and J. Williams Circulating IL-6 as a predictor of radiation pneumonitis Int J Radiat Oncol Biol Phys 49 2001 641 648